Literature DB >> 18416475

Study on vasculogenic mimicry in malignant esophageal stromal tumors.

Hui Zhao1, Xiao-Meng Gu.   

Abstract

AIM: To investigate whether malignant esophageal stromal tumors contain PAS-positive patterned matrix-associated vascular channels, which are lined by tumor cells, but not vascular endothelial cells. That is vasculogenic mimicry (VM) independent of tumor angiogenesis.
METHODS: Thirty-six tissue samples of malignant esophageal stromal tumors were analyzed. Tissue sections were stained for Vascular endothelial growth factor (VEGF), CD31 and periodic acid Schiff (PAS). The level of VEGF, the microvascular density (MVD) and the vasculogenic mimicry density (VMD) were determined.
RESULTS: PAS-positive patterned matrix-associated vascular channels were detected in 33.3% (12/36) of tumor samples. Within these patterned channels, red blood cells were found. The level of VEGF and the MVD in tumors containing patterned channels were significantly higher than those in tumors not containing patterned channels (P < 0.05). At the same time, the malignant degree of tumors was higher, the proportions of tumors containing patterned channels were not only more, but also in the each kind of tumors containing patterned channels.
CONCLUSION: In malignant esophageal stromal tumors, a VM mechanism causes some tumor cells to deform themselves and secrete extracellular matrix; thus, PAS-positive patterned matrix-associated vascular channels appear and supplying blood to the tumors to sustain their growth and metastasis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18416475      PMCID: PMC2705103          DOI: 10.3748/wjg.14.2430

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  9 in total

1.  Hemodynamics in vasculogenic mimicry and angiogenesis of inflammatory breast cancer xenograft.

Authors:  Kazuo Shirakawa; Hisataka Kobayashi; Yuji Heike; Satomi Kawamoto; Martin W Brechbiel; Fujio Kasumi; Toshihiko Iwanaga; Fumio Konishi; Masaaki Terada; Hiro Wakasugi
Journal:  Cancer Res       Date:  2002-01-15       Impact factor: 12.701

Review 2.  The GIST of targeted cancer therapy: a tumor (gastrointestinal stromal tumor), a mutated gene (c-kit), and a molecular inhibitor (STI571).

Authors:  Ronald P DeMatteo
Journal:  Ann Surg Oncol       Date:  2002-11       Impact factor: 5.344

3.  Molecular regulation of tumor cell vasculogenic mimicry by tyrosine phosphorylation: role of epithelial cell kinase (Eck/EphA2).

Authors:  A R Hess; E A Seftor; L M Gardner; K Carles-Kinch; G B Schneider; R E Seftor; M S Kinch; M J Hendrix
Journal:  Cancer Res       Date:  2001-04-15       Impact factor: 12.701

Review 4.  Gastrointestinal stromal tumors--definition, clinical, histological, immunohistochemical, and molecular genetic features and differential diagnosis.

Authors:  M Miettinen; J Lasota
Journal:  Virchows Arch       Date:  2001-01       Impact factor: 4.064

5.  Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry.

Authors:  A J Maniotis; R Folberg; A Hess; E A Seftor; L M Gardner; J Pe'er; J M Trent; P S Meltzer; M J Hendrix
Journal:  Am J Pathol       Date:  1999-09       Impact factor: 4.307

6.  Tumor blood vessels formation in osteosarcoma: vasculogenesis mimicry.

Authors:  Xuan-song Cai; Yong-wei Jia; Jiong Mei; Ru-yong Tang
Journal:  Chin Med J (Engl)       Date:  2004-01       Impact factor: 2.628

7.  Phosphoinositide 3-kinase regulates membrane Type 1-matrix metalloproteinase (MMP) and MMP-2 activity during melanoma cell vasculogenic mimicry.

Authors:  Angela R Hess; Elisabeth A Seftor; Richard E B Seftor; Mary J C Hendrix
Journal:  Cancer Res       Date:  2003-08-15       Impact factor: 12.701

8.  Tumoral angiogenesis and tissue factor expression during hepatocellular carcinoma progression in a transgenic mouse model.

Authors:  Evelyne Dupuy; Patricia Hainaud; Aude Villemain; Eva Bodevin-Phèdre; Jean Philippe Brouland; Pascale Briand; Gérard Tobelem
Journal:  J Hepatol       Date:  2003-06       Impact factor: 25.083

9.  [Microarray study of vasculogenic mimicry in bi-directional differentiation malignant tumor].

Authors:  Xishan Hao; Baocun Sun; Shiwu Zhang; Xiulan Zhao
Journal:  Zhonghua Yi Xue Za Zhi       Date:  2002-10-10
  9 in total
  10 in total

1.  Vasculogenic mimicry and aberrant expression of HIF-lα/E-cad are associated with worse prognosis of esophageal squamous cell carcinoma.

Authors:  Da-Min Chai; Zheng-Qi Bao; Jian-Guo Hu; Li Ma; Zhen-Zhong Feng; Yi-Sheng Tao
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2013-06-17

2.  Clinical significance of vasculogenic mimicry, vascular endothelial cadherin and SOX4 in patients with esophageal squamous cell carcinoma.

Authors:  Yanzi Qin; Wenjun Zhao; Lili Cheng; Shiwu Wu; Qiong Wu; Jin Gao; Zhaonan Bian; Li Ma
Journal:  Int J Clin Exp Pathol       Date:  2019-07-01

3.  Molecular regulation of vasculogenic mimicry in tumors and potential tumor-target therapy.

Authors:  Yue-Zu Fan; Wei Sun
Journal:  World J Gastrointest Surg       Date:  2010-04-27

Review 4.  Mechanisms of vasculogenic mimicry in hypoxic tumor microenvironments.

Authors:  Xiaoxu Wei; Yunhua Chen; Xianjie Jiang; Miao Peng; Yiduo Liu; Yongzhen Mo; Daixi Ren; Yuze Hua; Boyao Yu; Yujuan Zhou; Qianjin Liao; Hui Wang; Bo Xiang; Ming Zhou; Xiaoling Li; Guiyuan Li; Yong Li; Wei Xiong; Zhaoyang Zeng
Journal:  Mol Cancer       Date:  2021-01-04       Impact factor: 27.401

5.  Clinical significance of vasculogenic mimicry in human gliomas.

Authors:  Xiao-mei Liu; Qing-ping Zhang; Yong-gao Mu; Xiang-hen Zhang; Ke Sai; Jesse Chung-Sean Pang; Ho-Keung Ng; Zhong-ping Chen
Journal:  J Neurooncol       Date:  2011-04-30       Impact factor: 4.130

6.  Glioblastoma vasculogenic mimicry: signaling pathways progression and potential anti-angiogenesis targets.

Authors:  Jin-Ming Mao; Jing Liu; Geng Guo; Xing-Gang Mao; Chang-Xin Li
Journal:  Biomark Res       Date:  2015-04-18

7.  Microvessels Density in Uterine Leiomyosarcoma.

Authors:  Marcin Bobiński; Wiesława Bednarek; Justyna Szumiło; Marek Cybulski; Grzegorz Polak; Jan Kotarski
Journal:  Biomed Res Int       Date:  2015-06-16       Impact factor: 3.411

8.  Vasculogenic mimicry is associated with increased tumor-infiltrating neutrophil and poor outcome in esophageal squamous cell carcinoma.

Authors:  Jingxin Zhang; Guoxia Zhang; Pingping Hu; Guodong Deng; Qiqi Liu; Lili Qiao; Hui Luo; Jiandong Zhang
Journal:  Onco Targets Ther       Date:  2017-06-09       Impact factor: 4.147

9.  Relationship between the expression of ARHGAP25 and RhoA in non-small cell lung cancer and vasculogenic mimicry.

Authors:  Fan Shi; Jiatao Wu; Qianhao Jia; Kairui Li; Wenjuan Li; Yuqi Shi; Yufei Wang; Shiwu Wu
Journal:  BMC Pulm Med       Date:  2022-10-07       Impact factor: 3.320

Review 10.  Vasculogenic mimicry: a novel target for glioma therapy.

Authors:  Yin-Sheng Chen; Zhong-Ping Chen
Journal:  Chin J Cancer       Date:  2013-07-02
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.